Fingolimod hydrochloride
-
Fingolimod hydrochloride
structure -
-
CAS No:
162359-56-0
-
Formula:
C19H33NO2.ClH
-
Chemical Name:
Fingolimod hydrochloride
-
Synonyms:
1,3-Propanediol,2-amino-2-[2-(4-octylphenyl)ethyl]-,hydrochloride (1:1);1,3-Propanediol,2-amino-2-[2-(4-octylphenyl)ethyl]-,hydrochloride;FTY 720;Fingolimod hydrochloride;2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride;Gilenya;Imusera;2-Amino-[2-(4-octylphenyl)ethyl]-1,3-propanediol hydrochloride
- Categories:
-
CAS No:
Description
White SolidChEBI: The hydrochloride salt of 2-amino-2-[2-(4-octylphenyl) ethyl]-1,3-propanediol (fingolimod).Approved by the U.S. FDA in September 2010, fingolimod (also referredto as FTY720) is the first approved oral therapy for the relapsing-remittingform ofmultiple sclerosis (RRMS). Because of fingolimod’s structuralresemblance to sphingosine, a metabolite of sphingolipids that constitutesthe cell membrane of all eukaryotic cells, it was hypothesized thatfingolimod may be affectin
Fingolimod hydrochloride is the hydrochloride salt of 2-amino-2-[2-(4-octylphenyl) ethyl]-1,3-propanediol (fingolimod). It has a role as a sphingosine-1-phosphate receptor agonist, an immunosuppressive agent and a prodrug. It is a hydrochloride and an organic salt. It contains a fingolimod(1+).|Fingolimod Hydrochloride is the hydrochloride salt form of fingolimod, an orally available derivate of myriocin and sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) modulator, with potential anti-inflammatory and immunomodulating activities. Upon oral administration, fingolimod, as a structural analogue of sphingosine, selectively targets and binds to S1PR1 on lymphocytes and causes transient receptor activation followed by S1PR1 internalization and degradation. This results in the sequestration of lymphocytes in lymph nodes. By preventing egress of lymphocytes. fingolimod reduces both the amount of circulating peripheral lymphocytes and the infiltration of lymphocytes into target tissues. This prevents a lymphocyte-mediated immune response and may reduce inflammation. S1PR1, a G-protein coupled receptor, plays a key role in lymphocyte migration from lymphoid tissues. Fingolimod also shifts macrophages to an anti-inflammatory M2 phenotype, and modulates their proliferation, morphology, and cytokine release via inhibition of the transient receptor potential cation channel, subfamily M, member 7 (TRPM7).|A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.
Fingolimod hydrochloride Basic Attributes
343.93
343.227814
1308068-626-2
G926EC510T
DTXSID00167364
C72782
L04AA27
29221990
Characteristics
66.5
4.70660
white to beige
1.016g/cm3
107-108 °C
479.5ºC at 760 mmHg
243.8ºC
1.531
water: soluble10mg/mL, clear
-20°C Freezer
5.28E-10mmHg at 25°C
LD50 orally in rats: 300-600 mg/kg (Troncoso)
Safety Information
NONH for all modes of transport
3
36/37/38-52/53
26-61
TY3130000
Xi
P261-P273-P305 + P351 + P338
H315-H319-H335-H412
|Warning|H315 (84.91%): Causes skin irritation [Warning Skin corrosion/irritation]|P201, P202, P260, P261, P263, P264, P270, P271, P273, P280, P281, P302+P352, P304+P340, P305+P351+P338, P308+P313, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 107 companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Gilenya is indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult patients and paediatric patients aged 10 years and older:Patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4.4 and 5.1).orPatients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more Gadolinium enhancing lesions on brain MRI or a significant increase in T2 lesion load as compared to a previous recent MRI.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)|Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS. (See all compounds classified as Sphingosine 1 Phosphate Receptor Modulators.)
2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol hydrochloride
Fingolimod hydrochloride Use and Manufacturing
A cell-permeable aminopropanediol immunosuppressive agent that displays lymphocyte sequestration properties. Fingolimod is a sphingosine-l-phosphate (S1PR) receptor modulator, which binds to the s1P receptor on the surface of lymphocytes after phosphorylation in the body, changes the migration of lymphocytes, and promotes cells to enter lymphatic tissues. Prevent it from leaving the lymphatic tissue and enter the graft, thereby preventing these cells from infiltrating the central nervous system (CNS), thereby achieving the effect of immunosuppression.
Human drugs -> Gilenya -> EMA Drug Category|Immunosuppressants -> Human pharmacotherapeutic group|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:343.9
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:12
Exact Mass:343.2278070
Monoisotopic Mass:343.2278070
Topological Polar Surface Area:66.5
Heavy Atom Count:23
Complexity:258
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Recommended Suppliers of Fingolimod hydrochloride
-
CN
3 YRS
Business licensedTrader Supplier of Estradiol,Progesterone,GS441524,4-Butylresorcinol,DeoxyArbutin,Coenzyme Q10,Piracetam,Pregabalin,Ketoprofen,omeprazole,Fullerene C60,Melatonin,Nicotinamide riboside chloride,lactoferrin,Tylosin tartrate,Gentamycin Sulfate,Levamisole HCl,Praziquantel,Ivermectin,GA3,Pepsin,MT2,5 amino 1MQ,selank,semaxInquiryCAS No.: 162359-56-0Grade: Pharmaceutical GradeContent: 99% -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 162359-56-0Grade: Industrial GradeContent: 99% -
CN
1 YR
Business licensedTrader Supplier of Peptides,API,IntermediateInquiryCAS No.: 162359-56-0Grade: medical gradeContent: 98% -
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Herb Extracts,Cosmetic raw materails,APIInquiryCAS No.: 162359-56-0Content: 99.00%
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9